Table 2 Clinical results of both TVT surgery and TOT surgery
TVT surgery | TOT surgery | p Value | ||
|---|---|---|---|---|
surgical duration (min) | 37.4 ± 15.7 | 31.0 ± 8.3 | 0.0253* | |
blood loss (ml) | 0.9 ± 5.1 | 3.1 ± 10.2 | 0.2427* | |
catheterization (day) | 2.4 ± 1.4 | 2.0 ± 0.2 | 0.1020* | |
admission (day) | 3.3 ± 0.9 | 3.3 ± 0.7 | 0.7748* | |
subcutaneous hematoma | 2(5.3%) | 1(2.2%) | 0.5917** | |
post-operative urinary retention | 3(7.9%) | 0 | 0.1765** | |
maximum urine flow rate (ml/s) | 14.0 ± 6.8 | 13.4 ± 5.5 | 0.6477* | |
post-operative day 1 | average urine flow rate (ml/s) | 8.9 ± 5.5 | 8.6 ± 4.5 | 0.7798* |
post-voiding residue (ml) | 25.9 ± 44.2 | 10.6 ± 17.2 | 0.0452* | |
maximum urine flow rate (ml/s) | 18.5 ± 7.7 | 16.5 ± 10.9 | 0.4245* | |
post-operative month 3 | average urine flow rate (ml/s) | 11.9 ± 6.6 | 9.1 ± 6.1 | 0.1059* |
post-voiding residue (ml) | 33.4 ± 56.9 | 26.2 ± 48.4 | 0.577* | |
post-operative ICIQ-SF | 1.5 ± 2.6 | 3.2 ± 4.8 | 0.1152* | |
post-operative dysuria | 6(15.8%) | 1(2.2%) | 0.0574** | |
recurrence | 0 | 1(2.2%) | > .9999** | |
erosion | 0 | 1(2.2%) | > .9999** | |